a year ago
MDXH
AnalystsThomas FlatenThomas Flaten's Stock Forecasts
AnalystsThomas Flaten
Analyst Ranking
Bottom 6%
#5262 out of 5550 analysts
Average Return
-9.04%
Win Rate
29%17 out of 59
Risk vs Reward
Poor
Good
Thomas Flaten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Biodesix IncBDSX | +232.73% | $4.40 | $14.64 | 2025-05-14 - 2026-05-13 | Strong Buy |
Diamedica Therapeutics IncDMAC | +220.63% | $1.26 | $4.04 | 2022-07-07 - 2023-07-06 | Strong Buy |
Personalis IncPSNL | +158.50% | $1.47 | $3.80 | 2024-04-30 - 2025-04-29 | Strong Buy |
Biolife Solutions IncBLFS | +152.95% | $15.77 | $39.89 | 2020-02-24 - 2021-02-24 | Strong Buy |
Castle Biosciences IncCSTL | +101.72% | $11.66 | $23.52 | 2023-06-05 - 2024-06-04 | Strong Buy |
Thomas Flaten Analyst Color
Get additional color on Thomas Flaten's coverage of popular stocks
3 years ago
ASRT
Thomas Flaten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pelthos Therapeutics IncPTHS | 2 | Strong Buy | $40.00 | +325.53% | Maintains | 21 days ago |
Aeon Biopharma IncAEON | 2 | Strong Buy | $2.00 | +629.93% | Maintains | a month ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Strong Buy | $20.00 | +340.53% | Initiates Coverage On | a month ago |
Alterity Therapeutics LtdATHE | 1 | Strong Buy | $10.00 | +362.96% | Initiates Coverage On | 2 months ago |
Mdxhealth SaMDXH | 3 | Strong Buy | $3.00 | +1,740.49% | Maintains | 3 months ago |
Biolife Solutions IncBLFS | 3 | Hold | $31.00 | -19.71% | Downgrades | 3 months ago |
Personalis IncPSNL | 3 | Hold | $16.25 | +2.72% | Downgrades | 3 months ago |
Vivani Medical IncVANI | 1 | Strong Buy | $4.00 | +266.97% | Initiates Coverage On | 4 months ago |
Rapid Micro Biosystems IncRPID | 2 | Strong Buy | $7.00 | +851.09% | Maintains | 5 months ago |
Assertio Holdings IncASRT | 5 | Hold | $23.50 | 0.00% | Maintains | 6 months ago |
Evaxion AEVAX | 4 | Strong Buy | $9.00 | +207.17% | Maintains | 8 months ago |
Insight Molecular Diagnostics IncIMDX | 6 | Strong Buy | $12.00 | +305.41% | Maintains | 9 months ago |
Castle Biosciences IncCSTL | 7 | Strong Buy | $52.00 | +39.94% | Maintains | 10 months ago |
Connect Biopharma Holdings LtdCNTB | 1 | Strong Buy | $9.00 | +1,022.19% | Initiates Coverage On | a year ago |
Harrow IncHROW | 1 | Strong Buy | $70.00 | N/A | Maintains | a year ago |
Journey Medical CorpDERM | 2 | Strong Buy | $13.00 | N/A | Maintains | a year ago |
Diamedica Therapeutics IncDMAC | 2 | Strong Buy | $14.00 | N/A | Maintains | a year ago |
Aytu Biopharma IncAYTU | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | a year ago |
Biodesix IncBDSX | 1 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Optinose IncOPTN | 4 | Hold | $9.00 | N/A | Downgrades | 2 years ago |
Checkpoint Therapeutics IncCKPT | 5 | Hold | $4.10 | N/A | Downgrades | 2 years ago |
Aquestive Therapeutics IncAQST | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Dermtech IncDMTKQ | 1 | Hold | $0.63 | N/A | Downgrades | 3 years ago |
Achieve Life Sciences IncACHV | 3 | Strong Buy | $11.00 | N/A | Maintains | 3 years ago |
Better Therapeutics IncBTTX | 2 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Fresh Tracks Therapeutics IncFRTX | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Ensysce Biosciences IncENSC | 1 | Strong Buy | $14,400.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.